Bayesian Capital Management, LP Shockwave Medical, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $498,908 - $668,423	-3,099 Reduced 65.16%	1,657 $315,000
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $924,233 - $1.35 Million	4,756 New	4,756 $946,000
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $1.59 Million - $1.97 Million	9,047 New	9,047 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $391,396 - $622,612	2,005 New	2,005 $558,000
Q2 2022 Aug 15, 2022	SELL	$115.91 - $214.48 $828,176 - $1.53 Million	-7,145 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$127.96 - $207.36 $914,274 - $1.48 Million	7,145 New	7,145 $1.48 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.